Elizabeth A. Garofalo, Director at Xenon Pharmaceuticals Inc. (XENE), sold 5,592 shares at $45.69 ($256K) on 2024-03-08, disclosed to the SEC on 2024-03-11.
Open-market sale of $256k XENE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.69 | 2,092 | $96K | 37.3% |
| 2 | $45.69 | 2,092 | $96K | 37.3% |
| 3 | $46.16 | 1,408 | $65K | 25.4% |
| Total | $45.81 avg | 5,592 | $256K | 100% |
| Filing → |